Studienlage · Detail
Gemischt
GRADE
Niedrig
198 Zitate
Stichproben = 311 Pat.
DauerCross-sectional survey
KontrolleNicht-cannabis-abhängiger bzw. später…
EndpunktMDD, Suizidideen…
Verblindungn.a.
DesignKohortenstudie
Kernaussage
Cannabis-Abhängigkeit war mit 2,5–2,9fach höheren Quoten für Suizidgedanken und Suizidversuch assoziiert; früher Cannabis-Gebrauch (vor 17 Jahren) zeigte erhöhte Suizidversuch-Raten, aber keine MDD-Assoziation nach genetischer Kontrolle.
Zusammenfassung
n=311 Zwillingspaare diskordant für Cannabis-Abhängigkeit; erhöhtes Risiko für Major Depression (OR=2.8, 95% CI 1.5-5.3) und Suizidgedanken bei Cannabis-abhängigen Zwillingen; genetisch kontrollierte Risiko-Assoziation.
P
PopulationZwillingspaare diskordant für Cannabis-Abhängigkeit (n=277 Paare) und diskordant für frühen Cannabis-Konsum <17 Jahre (n=311 Paare), Median-Alter 30 Jahre
I
InterventionLifetime Cannabis-Abhängigkeit (DSM-IV) bzw. früher Cannabis-Konsum (Beginn vor 17. Lebensjahr)
C
KontrolleNicht-cannabis-abhängiger bzw. später konsumierender Co-Zwilling
O
OutcomeSuizidgedanken OR 2.5-2.9 (p<0.05), Suizidversuch OR 3.5 (95% CI 1.4-8.6) bei frühem Konsum; MDD-Assoziation nur in dizygoten Paaren, nicht monozygot
Vertrauen in die Evidenz
Niedrig
Zweite von vier GRADE-Stufen, die Effektschätzung ist begrenzt verlässlich.
Qualitätsprofil
Größe
★★★★★
Verblindung
—
Effektstärke
Gemischt
Zitate / Jahr
★★★★★
Autoren
Teilen
Abstract
Background: Previous research has reported both a moderate degree of comorbidity between cannabis dependence and major depressive disorder (MDD) and that early-onset cannabis use is associated with increased risks for MDD.
Objective: To examine whether associations between both lifetime cannabis dependence and early cannabis use and measures of MDD, suicidal ideation, and suicide attempt persist after controlling for genetic and/or shared environmental influences.
Design: Cross-sectional survey of twin pairs discordant for lifetime cannabis dependence and those discordant for early cannabis use.
Setting: General population sample of twins (median age, 30 years).
Participants: Two hundred seventy-seven same-sex twin pairs discordant for cannabis dependence and 311 pairs discordant for early-onset cannabis use (before age 17 years).
Main Outcome Measures: Self-report measures of DSM-IV-defined lifetime MDD, suicidal ideation, and suicide attempt.
Results: Individuals who were cannabis dependent had odds of suicidal ideation and suicide attempt that were 2.5 to 2.9 times higher than those of their non-cannabis-dependent co-twin. Additionally, cannabis dependence was associated with elevated risks of MDD in dizygotic but not in monozygotic twins. Those who initiated cannabis use before age 17 years had elevated rates of subsequent suicide attempt (odds ratio, 3.5 [95% confidence interval, 1.4-8.6]) but not of MDD or suicidal ideation. Early MDD and suicidal ideation were significantly associated with subsequent risks of cannabis dependence in discordant dizygotic pairs but not in discordant monozygotic pairs.
Conclusions: Comorbidity between cannabis dependence and MDD likely arises through shared genetic and environmental vulnerabilities predisposing to both outcomes. In contrast, associations between cannabis dependence and suicidal behaviors cannot be entirely explained by common predisposing genetic and/or shared environmental predispositions. Previously reported associations between early-onset cannabis use and subsequent MDD likely reflect shared genetic and environmental vulnerabilities, although it remains possible that early-onset cannabis use may predispose to suicide attempt.
„Was dem Handeln im Weg steht, wird zum Weg.“